We are live on
!
Find out more
Wealthfront Advisers Portfolio holdings
AUM
$45.6B
1-Year Est. Return
18.83%
This Fund
S&P 500
This Quarter
Est. Return
+9.35%
1 Year Est. Return
+18.83%
3 Year Est. Return
+48.65%
5 Year Est. Return
+44%
10 Year Est. Return
–
AUM
$38.8B
AUM Growth
+$1.58B
(+4.2%)
Cap. Flow
+$643M
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
56.9%
Holding
987
New
53
Increased
543
Reduced
365
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$344M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$288M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$162M |
| 4 |
Invesco California AMT-Free Municipal Bond ETF
PWZ
|
+$117M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core Dividend Growth ETF
DGRO
|
+$219M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$204M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$137M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$97.9M |
| 5 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$71.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.82% |
| 2 | Financials | 2.61% |
| 3 | Communication Services | 1.87% |
| 4 | Consumer Discretionary | 1.84% |
| 5 | Healthcare | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Motley Fool 100 Index ETF
TMFC
$2.04B
| $3.9M | 0.01% |
60,436
+1,244
| +2% | +$73K |
|
427
Nucor
NUE
$52.5B
| $3.89M | 0.01% |
30,061
-12,827
| -30% | -$1.5M |
|
428
Schwab U.S Small- Cap ETF
SCHA
$22.5B
| $3.85M | 0.01% |
152,013
-17,997
| -11% | -$425K |
|
429
Steel Dynamics
STLD
$33.2B
| $3.8M | 0.01% |
29,722
-4,201
| -12% | -$536K |
|
430
Healthpeak Properties
DOC
$15.4B
| $3.79M | 0.01% |
216,485
-64,810
| -23% | -$1.15M |
|
431
Alexandria Real Estate Equities
ARE
$8.72B
| $3.78M | 0.01% |
52,079
+10,442
| +25% | +$776K |
|
432
Cummins
CMI
$88.2B
| $3.76M | 0.01% |
11,493
+705
| +7% | +$218K |
|
433
Zoetis
ZTS
$31.9B
| $3.76M | 0.01% |
24,123
-90
| -0.4% | -$14.3K |
|
434
Idexx Laboratories
IDXX
$44.5B
| $3.76M | 0.01% |
7,014
+468
| +7% | +$224K |
|
435
State Street Health Care Select Sector SPDR ETF
XLV
$41.2B
| $3.73M | 0.01% |
27,696
-779
| -3% | -$105K |
|
436
Willis Towers Watson
WTW
$27.7B
| $3.69M | 0.01% |
12,027
-842
| -7% | -$261K |
|
437
Carnival Corporation Ltd
CCL
$35.7B
| $3.67M | 0.01% |
130,419
+11,447
| +10% | +$245K |
|
438
Centene
CNC
$32.5B
| $3.63M | 0.01% |
66,790
+43,595
| +188% | +$2.56M |
|
439
Electronic Arts
EA
$52.5B
| $3.62M | 0.01% |
22,642
+347
| +2% | +$51.3K |
|
440
Rocket Lab Corp
RKLB
$41.1B
| $3.59M | 0.01% |
100,301
-1,649
| -2% | -$40.4K |
|
441
Otis Worldwide
OTIS
$28.2B
| $3.58M | 0.01% |
36,133
-7,173
| -17% | -$692K |
|
442
CSX Corp
CSX
$93.1B
| $3.56M | 0.01% |
109,210
+44,231
| +68% | +$1.33M |
|
443
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
| $3.56M | 0.01% |
67,453
+2,459
| +4% | +$128K |
|
444
Fox Class B
FOX
$21.6B
| $3.55M | 0.01% |
68,696
+19,275
| +39% | +$938K |
|
445
ResMed
RMD
$28.8B
| $3.52M | 0.01% |
13,630
+4,250
| +45% | +$1.01M |
|
446
Xylem
XYL
$28.7B
| $3.5M | 0.01% |
27,047
+1,507
| +6% | +$183K |
|
447
Vanguard Mid-Cap ETF
VO
$105B
| $3.48M | 0.01% |
49,740
+204
| +0.4% | +$13.4K |
|
448
Zebra Technologies
ZBRA
$12.6B
| $3.48M | 0.01% |
11,275
-1,795
| -14% | -$487K |
|
449
Clorox
CLX
$11.6B
| $3.47M | 0.01% |
28,881
+4,634
| +19% | +$618K |
|
450
Ferguson
FERG
$44.4B
| $3.47M | 0.01% |
15,913
+3,141
| +25% | +$578K |
|
Similar funds
LP
AS
TI
Wealthfront Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Wealthfront Advisers held 987 positions worth $38.8B, up 4.2% from $37.3B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Wealthfront Advisers's Q2 2025 filing shows 53 new, 543 increased, 365 reduced and 24 closed positions. Its largest new stake was Oscar Health: 43,841 shares worth $940K. The largest sale was iShares Core Dividend Growth ETF, an estimated $219M.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 4.7% a quarter earlier, followed by Financials and Communication Services.
- Wealthfront Advisers's largest Q2 2025 buy was Oscar Health: 43,841 shares worth $940K.
- Wealthfront Advisers added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $344M increase.
- Wealthfront Advisers's biggest Q2 2025 reduction was iShares Core Dividend Growth ETF, cutting an estimated $219M.
- Wealthfront Advisers fully exited Campbell Soup in Q2 2025, selling an estimated $7.94M.
- Wealthfront Advisers's ten largest holdings make up 57% of its $38.8B portfolio in Q2 2025.
- Wealthfront Advisers opened 53 new positions and closed 24 in Q2 2025.
- Wealthfront Advisers's portfolio value rose 4.2% quarter-over-quarter to $38.8B.
Based on Wealthfront Advisers's 13F filing for Q2 2025, filed 31 Jul 2025.